Product
mRNA Vaccine
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Randomized, Double-blinded, Active-controlled Phase II Clinical Study to Evaluate the Immunogenicity and Safety of SCTV01C (A Bivalent SARS-CoV-2 Trimeric Spike Protein Vaccine) and SCTV01E (A COVID-19 Alpha/Beta/Delta/Omicron Variants S-Trimer Vaccine) in Population Aged ≥12 Years and Previously UnvaccinatedStatus: Withdrawn, Estimated PCD: 2022-08-01